154 related articles for article (PubMed ID: 17617445)
1. C-reactive protein is a prognostic parameter in patients with cervical cancer.
Polterauer S; Grimm C; Tempfer C; Sliutz G; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2007 Oct; 107(1):114-7. PubMed ID: 17617445
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
[TBL] [Abstract][Full Text] [Related]
3. Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer.
Schmid M; Schneitter A; Hinterberger S; Seeber J; Reinthaller A; Hefler L
Obstet Gynecol; 2007 Dec; 110(6):1231-6. PubMed ID: 18055714
[TBL] [Abstract][Full Text] [Related]
4. Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis.
Polterauer S; Grimm C; Zeillinger R; Heinze G; Tempfer C; Reinthaller A; Hefler L
Anticancer Res; 2011 Jun; 31(6):2259-64. PubMed ID: 21737650
[TBL] [Abstract][Full Text] [Related]
5. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer.
Polterauer S; Seebacher V; Hefler-Frischmuth K; Grimm C; Heinze G; Tempfer C; Reinthaller A; Hefler L
Am J Obstet Gynecol; 2009 Jun; 200(6):647.e1-7. PubMed ID: 19306966
[TBL] [Abstract][Full Text] [Related]
7. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
[TBL] [Abstract][Full Text] [Related]
8. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
Hefler LA; Concin N; Hofstetter G; Marth C; Mustea A; Sehouli J; Zeillinger R; Leipold H; Lass H; Grimm C; Tempfer CB; Reinthaller A
Clin Cancer Res; 2008 Feb; 14(3):710-4. PubMed ID: 18245530
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
[TBL] [Abstract][Full Text] [Related]
10. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of preoperative serum high sensitivity C-reactive protein in patients with endometrial cancer].
Wang LJ; Zhou H; Lu HW; Li J; Lin ZQ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(41):2927-30. PubMed ID: 22333616
[TBL] [Abstract][Full Text] [Related]
12. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A; Tana R; Fanucchi A; Genazzani AR
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
Polterauer S; Grimm C; Seebacher V; Concin N; Marth C; Tomovski C; Husslein H; Leipold H; Hefler-Frischmuth K; Tempfer C; Reinthaller A; Hefler L
Oncologist; 2009 Oct; 14(10):979-85. PubMed ID: 19776095
[TBL] [Abstract][Full Text] [Related]
15. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
16. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
Wang CY; Hsieh MJ; Chiu YC; Li SH; Huang HW; Fang FM; Huang YJ
Radiother Oncol; 2009 Aug; 92(2):270-5. PubMed ID: 19195729
[TBL] [Abstract][Full Text] [Related]
17. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
[TBL] [Abstract][Full Text] [Related]
18. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].
Goudy G; Stoeckle E; Thomas L; Kind M; Guyon F; Brouste V; Floquet A
Bull Cancer; 2009 Jun; 96(6):685-94. PubMed ID: 19467961
[TBL] [Abstract][Full Text] [Related]
20. Is C-reactive protein a prognostic factor of colorectal cancer?
Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]